Veteran private equity investor focused on mid-market buyouts and operational value creation, PETER KRUSSEL combines deal sourcing, portfolio oversight and board-level transformation to drive exits and EBITDA expansion. Experience spans sector-specialist investing, operational turnarounds and capital structure optimization. Regularly engages with management teams on strategic execution, governance and M&A to maximize investor returns.
Veteran private equity investor focused on mid-market buyouts and operational value creation, PETER KRUSSEL combines deal sourcing, portfolio oversight and board-level transformation to drive exits and EBITDA expansion. Experience spans sector-specialist investing, operational turnarounds and capital structure optimization. Regularly engages with management teams on strategic execution, governance and M&A to maximize investor returns.
Seasoned mid‑market private equity investor emphasizing operationally-led buyouts and EBITDA expansion. Prioritizes concentrated, control-oriented investments where active governance, management alignment and hands-on transformation unlock multiple expansion. Capital allocation favors firms with stable cash generation, clear cost and growth levers, and strategic M&A optionality. Investment horizon typically 3–7 years with value creation milestones tied to margin improvement, working capital optimization and selective add‑ons. Risk discipline centers on conservative leverage, staged capital deployment and board-level oversight to de-risk exits.
Seasoned mid‑market private equity investor emphasizing operationally-led buyouts and EBITDA expansion. Prioritizes concentrated, control-oriented investments where active governance, management alignment and hands-on transformation unlock multiple expansion. Capital allocation favors firms with stable cash generation, clear cost and growth levers, and strategic M&A optionality. Investment horizon typically 3–7 years with value creation milestones tied to margin improvement, working capital optimization and selective add‑ons. Risk discipline centers on conservative leverage, staged capital deployment and board-level oversight to de-risk exits.
| Trades 4359 | Longs Won 3032/4359 69% | Profit Factor 11.71 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $385,537.35 |
| Average Win $65,612.75 | Best Trade (Oct 16) $19.55M | Sharpe Ratio -10.02 |
| Average Loss -$12,806.33 | Worst Trade (Oct 15) -$786,529.87 | Z-Score 23.95 (100%) |
| Commissions $0 | Avg. Trade Length 2y 3m 3w | Expectancy $41,739.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 45,455 | 40,909 | 36,364 | 31,818 | 27,273 | 22,727 | 18,182 | 13,636 | 9,091 | 4,545 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 121,344 | $16.73M | $41.85M | - | $25.12M | 150.14% | +0.846% |
ABBV AbbVie Inc. | 28,184 | $4.91M | $8.04M | - | $3.14M | 63.86% | +0.716% |
ABT Abbott Laboratories | 8,554 | $933,294.7 | $895,945.96 | - | -$37,348.74 | -4% | +0.057% |
ADI Analog Devices, Inc. | 640 | $253,995.86 | $260,707.2 | - | $6,711.34 | 2.64% | +0.843% |
AEP American Electric Power Company, Inc. | 4,869 | $483,752.63 | $617,048.37 | - | $133,295.74 | 27.55% | +1.963% |
AGNCO AGNC Investment Corp. 10.1219% Perpetual Preferred Stock | 21,186 | $529,861.86 | $531,768.6 | - | $1,906.74 | 0.36% | -0.159% |
AIQ Global X Artificial Intelligence & Technology ETF | 5,904 | $209,910.72 | $369,177.12 | - | $159,266.4 | 75.87% | -2.434% |
AIRR First Trust RBA American Industrial Renaissance ETF | 2,283 | $174,454.55 | $227,443.87 | - | $52,989.32 | 30.37% | -0.782% |
AMAT Applied Materials, Inc. | 1,704 | $310,056.8 | $714,180.48 | - | $404,123.68 | 130.34% | -2.533% |
AMD Advanced Micro Devices, Inc. | 1,256 | $182,200.7 | $682,259.2 | - | $500,058.5 | 274.45% | -3.385% |
AMGN Amgen Inc. | 1,403 | $369,658.78 | $610,669.78 | - | $241,011 | 65.2% | +0.283% |
AMLP Alerian MLP ETF | 4,445 | $211,413.42 | $232,517.95 | - | $21,104.53 | 9.98% | +0.771% |
AMZN Amazon.com Inc | 24,829 | $4.38M | $6.26M | - | $1.88M | 42.87% | -1.019% |
ARKG ARK Genomic Revolution ETF | 10,337 | $560,472 | $485,839 | - | -$74,633 | -13.32% | -4.549% |
AVGO Broadcom Inc. | 3,228 | $662,291.77 | $1.08M | - | $415,246.91 | 62.7% | -3.055% |
AWF AllianceBernstein Global High Income Fund Inc. | 16,514 | $160,213.69 | $158,451.83 | - | -$1,761.86 | -1.1% | -0.208% |
BAC Bank of America Corporation | 9,449 | $312,668.69 | $491,300.75 | - | $178,632.06 | 57.13% | +0.571% |
BALT Inn Defined Wealth Shield Mutual Fund | 120,315 | $4.2M | $4.21M | - | $13,852.86 | 0.33% | -0.097% |
BAPR Innovator U.S. Equity Buffer ETF | 30,306 | $986,871.1 | $1.66M | - | $676,776.77 | 68.58% | -0.1% |
BILZ PIMCO Ultra Short Government Active Exchange-Traded Fund | 47,984 | $4.85M | $4.84M | - | -$12,256.69 | -0.25% | +0.04% |